This pipeline uses various statistical tests to identify mRNAs whose expression levels correlated to selected clinical features.
Testing the association between 18108 genes and 3 clinical features across 134 samples, statistically thresholded by Q value < 0.05, 1 clinical feature related to at least one genes.
-
16 genes correlated to 'GENDER'.
-
ZFY|7544 , XIST|7503 , PRKY|5616 , RPS4Y1|6192 , DDX3Y|8653 , ...
-
No genes correlated to 'Time to Death', and 'AGE'.
Complete statistical result table is provided in Supplement Table 1
Clinical feature | Statistical test | Significant genes | Associated with | Associated with | ||
---|---|---|---|---|---|---|
Time to Death | Cox regression test | N=0 | ||||
AGE | Spearman correlation test | N=0 | ||||
GENDER | t test | N=16 | male | N=12 | female | N=4 |
Time to Death | Duration (Months) | 0.2-131.1 (median=41.8) |
censored | N = 6 | |
death | N = 10 | |
Significant markers | N = 0 |
AGE | Mean (SD) | 55.59 (17) |
Significant markers | N = 0 |
GENDER | Labels | N |
FEMALE | 45 | |
MALE | 89 | |
Significant markers | N = 16 | |
Higher in MALE | 12 | |
Higher in FEMALE | 4 |
T(pos if higher in 'MALE') | ttestP | Q | AUC | |
---|---|---|---|---|
ZFY|7544 | 28.55 | 1.327e-53 | 2.4e-49 | 0.9981 |
XIST|7503 | -19.6 | 5.998e-38 | 1.09e-33 | 0.976 |
PRKY|5616 | 22.39 | 7.549e-34 | 1.37e-29 | 0.9985 |
RPS4Y1|6192 | 25.39 | 3.324e-32 | 6.02e-28 | 1 |
DDX3Y|8653 | 27.43 | 7.84e-30 | 1.42e-25 | 1 |
KDM5D|8284 | 25.67 | 9.947e-23 | 1.8e-18 | 1 |
TSIX|9383 | -12.65 | 2.35e-21 | 4.25e-17 | 0.9613 |
EIF1AY|9086 | 23.36 | 4.574e-18 | 8.28e-14 | 1 |
TTTY15|64595 | 19.56 | 2.697e-15 | 4.88e-11 | 0.9972 |
USP9Y|8287 | 18.52 | 9.721e-15 | 1.76e-10 | 0.9983 |
-
Expresson data file = SKCM.uncv2.mRNAseq_RSEM_normalized_log2.txt
-
Clinical data file = SKCM.clin.merged.picked.txt
-
Number of patients = 134
-
Number of genes = 18108
-
Number of clinical features = 3
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.